{"id":"NCT03607838","sponsor":"Seikagaku Corporation","briefTitle":"SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)","officialTitle":"A Multicenter, Randomized, Double-blind, Sham-controlled, Comparative Study of SI-6603 in Subjects With Lumbar Disc Herniation (Phase 3)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-07","primaryCompletion":"2022-08-03","completion":"2023-03-21","firstPosted":"2018-07-31","resultsPosted":"2025-07-11","lastUpdate":"2025-07-24"},"enrollment":352,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Lumbar Disc Herniation"],"interventions":[{"type":"DRUG","name":"SI-6603","otherNames":[]},{"type":"DRUG","name":"Sham injection","otherNames":[]}],"arms":[{"label":"SI-6603","type":"EXPERIMENTAL"},{"label":"Sham","type":"SHAM_COMPARATOR"}],"summary":"This study is to evaluate the effectiveness of a single-dose intervertebral disc injection of SI-6603 in subjects with lumbar disc herniation (LDH)","primaryOutcome":{"measure":"Change From Baseline to Week 13 in Average Worst Leg Pain Score During the Past 24 Hours Over the Previous 7 Days","timeFrame":"baseline and 13 weeks","effectByArm":[{"arm":"SI-6603","deltaMin":-41.7,"sd":2.38},{"arm":"Sham","deltaMin":-34.2,"sd":2.36}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0263"}]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":67,"countries":["United States"]},"refs":{"pmids":["40066868"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":167},"commonTop":["Magnetic resonance imaging spinal abnormal","Back pain","Pain in extremity","COVID-19","Spinal X-ray abnormal"]}}